{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11006",
      "entity_text" : "CNS",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q99707",
      "entity_text" : "MS",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "As an example, MS patients treated with anti-alpha4 integrin (Natalizumab) to prevent immune cell CNS entry are at risk of developing progressive multi-focal leukoencephalopathy due to JC virus reactivation.",
  "reading_complete" : "2020-07-28T14:20:37Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:19:28Z",
  "trigger" : "prevent",
  "evidence" : [ "MS patients treated with anti-alpha4 integrin (Natalizumab) to prevent immune cell CNS" ],
  "pmc_id" : "5474352",
  "score" : 0
}